BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Treatment
66 results:

  • 1. Adjuvant chemotherapy and survival in males aged 70 years or older with breast cancer: a population-based retrospective study.
    Yu Y; Huang K; Liu Y; Chen R; Yu X; Song C
    BMC Geriatr; 2024 Mar; 24(1):282. PubMed ID: 38528444
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cost-effectiveness of one-year adjuvant trastuzumab therapy in treatment for early-stage breast cancer patients with HER2+ in Vietnam.
    Nguyen AQ; Tran OTM; Nguyen PK; Nguyen HT
    PLoS One; 2024; 19(3):e0300474. PubMed ID: 38489305
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Effects of Extended Fixation on Advanced Gastric cancer HER2 Status Assessment Using IHC and FISH.
    Kondo J; Yoshino S; Iida M; Takeda S; Nakashima C; Watanabe Y; Nishiyama M; Tokumitsu Y; Shindo Y; Nishimura T; Suzuki N; Hoshii Y; Itoh H; Nagano H
    Anticancer Res; 2024 Feb; 44(2):621-630. PubMed ID: 38307565
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Ki-67 Change in Anthracyline-containing Neoadjuvant Chemotherapy Response in breast cancer.
    Yang ZG; Ren LH; Wang F; Wang PL; Wang WY; Lin SY
    Curr Med Sci; 2024 Feb; 44(1):156-167. PubMed ID: 38302780
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Refining breast cancer biomarker discovery and drug targeting through an advanced data-driven approach.
    Rakhshaninejad M; Fathian M; Shirkoohi R; Barzinpour F; Gandomi AH
    BMC Bioinformatics; 2024 Jan; 25(1):33. PubMed ID: 38253993
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The Association between ER, PR, HER2, and ER-/PR+ Expression and Lung cancer Subsequent in breast cancer Patients: A Retrospective Cohort Study Based on SEER Database.
    Shao HY; Hao BT; Gao FX
    Breast J; 2023; 2023():7028189. PubMed ID: 38021219
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the heterogeneity of cancer-associated fibroblasts in TNBC.
    Wu X; Lu W; Zhang W; Zhang D; Mei H; Zhang M; Cui Y; Zhuo Z
    Aging (Albany NY); 2023 Nov; 15(21):12674-12697. PubMed ID: 37963845
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Deep Learning Radiomics Nomogram Based on Multiphase Computed Tomography for Predicting Axillary Lymph Node Metastasis in breast cancer.
    Zhang J; Yin W; Yang L; Yao X
    Mol Imaging Biol; 2024 Feb; 26(1):90-100. PubMed ID: 37563517
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Multimodality deep learning radiomics nomogram for preoperative prediction of malignancy of breast cancer: a multicenter study.
    Wu P; Jiang Y; Xing H; Song W; Cui X; Wu XL; Xu G
    Phys Med Biol; 2023 Aug; 68(17):. PubMed ID: 37524093
    [No Abstract]    [Full Text] [Related]  

  • 10. Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study.
    Wang DD; Zhang JF; Zhang LH; Niu M; Jiang HJ; Jia FC; Feng ST
    Hepatobiliary Pancreat Dis Int; 2023 Dec; 22(6):594-604. PubMed ID: 36456428
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Symptom burden, psychological distress, and symptom management status in hospitalized patients with advanced cancer: a multicenter study in China.
    He Y; Pang Y; Su Z; Zhou Y; Wang Y; Lu Y; Jiang Y; Han X; Song L; Wang L; Li Z; Lv X; Wang Y; Yao J; Liu X; Zhou X; He S; Zhang Y; Song L; Li J; Wang B; Tang L
    ESMO Open; 2022 Dec; 7(6):100595. PubMed ID: 36252435
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of breast cancer.
    Gil Del Alcazar CR; Trinh A; Alečković M; Rojas Jimenez E; Harper NW; Oliphant MUJ; Xie S; Krop ED; Lulseged B; Murphy KC; Keenan TE; Van Allen EM; Tolaney SM; Freeman GJ; Dillon DA; Muthuswamy SK; Polyak K
    Cancer Immunol Res; 2022 Jun; 10(6):680-697. PubMed ID: 35446942
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Preoperative comprehensive malignancy risk estimation for thyroid nodules: Development and verification of a network-based prediction model.
    Shao G; Sun B; Shi M; Song Y; Sun Z; Hao X; Li L; Fu Z
    Eur J Surg Oncol; 2022 Jun; 48(6):1264-1271. PubMed ID: 35367109
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative breast cancer via Regulation of Epigenetic Mechanisms.
    Sharma M; Arora I; Chen M; Wu H; Crowley MR; Tollefsbol TO; Li Y
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836197
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Associations between frailty and cancer-specific mortality among older women with breast cancer.
    Yan CH; Coleman C; Nabulsi NA; Chiu BC; Ko NY; Hoskins K; Calip GS
    Breast Cancer Res Treat; 2021 Oct; 189(3):769-779. PubMed ID: 34241741
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Bioinformatics reveal macrophages marker genes signature in breast cancer to predict prognosis.
    Li Y; Zhao X; Liu Q; Liu Y
    Ann Med; 2021 Dec; 53(1):1019-1031. PubMed ID: 34187256
    [No Abstract]    [Full Text] [Related]  

  • 17. Bone recurrence in early breast cancer patients: The paradox of aromatase inhibitors induced bone resorption.
    Pavese F; Parisi A; Rotondaro S; Cocciolone V; Pierorazio G; Sidoni T; Verna L; Porzio G; Ficorella C; Cannita K
    Breast Dis; 2021; 40(4):257-262. PubMed ID: 34092578
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A novel cd74-ROS1 gene fusion in a patient with inflammatory breast cancer: a case report.
    Hu H; Ding N; Zhou H; Wang S; Tang L; Xiao Z
    J Med Case Rep; 2021 May; 15(1):277. PubMed ID: 34051833
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic
    Odintsov I; Lui AJW; Sisso WJ; Gladstone E; Liu Z; Delasos L; Kurth RI; Sisso EM; Vojnic M; Khodos I; Mattar MS; de Stanchina E; Leland SM; Ladanyi M; Somwar R
    Clin Cancer Res; 2021 Jun; 27(11):3154-3166. PubMed ID: 33824166
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma.
    Boerner T; Drill E; Pak LM; Nguyen B; Sigel CS; Doussot A; Shin P; Goldman DA; Gonen M; Allen PJ; Balachandran VP; Cercek A; Harding J; Solit DB; Schultz N; Kundra R; Walch H; D'Angelica MI; DeMatteo RP; Drebin J; Kemeny NE; Kingham TP; Simpson AL; Hechtman JF; Vakiani E; Lowery MA; Ijzermans JNM; Buettner S; Koerkamp BG; Doukas M; Chandwani R; Jarnagin WR
    Hepatology; 2021 Sep; 74(3):1429-1444. PubMed ID: 33765338
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.